Peanut Allergy Vaccine Market To Be At Forefront By 2026

Peanut Allergy Vaccine Market Outlook 2018 Sales
Revenue, Strategy to 2026
Peanut Allergy Vaccine Market - Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some
external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the
skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various
allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of
administering antigenic material or a vaccine to stimulate one’s immune system to build up an adaptive
immunity to pathogens.
Request For Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/121
Food allergy is one of the major forms of allergies. Food allergies can be caused by cow’s milk, eggs,
shellfish, and many other foods, including peanuts. However, peanut allergy is very prevalent in the
present scenario, especially in children. Therefore, peanut allergy vaccine market is likely to gain
significant traction in the near future. Peanut allergy vaccine is administered to patients who are
detected with a probability of developing peanut allergy, so as to prevent occurrences of allergy attacks
such as anaphylaxis in the future. According to a report published by National Centre for
Biotechnology Information, allergy to peanuts as well as tree nuts (TNs) is the principal reason for fatal
allergic reactions in the U.S., and the occurrences appear to be rising. In this 11 year follow up
research, over 1% (around 3 million) people reported peanut or tree nut allergies and the condition has
been on the rise, mainly amongst children. According to a report by Food Allergy Research and
Education (FARE), peanuts caused the most number of allergies in the U.S., among all food allergens.
Hence, peanut allergy vaccine market has a major potential for growth in this region during the forecast
period (2018–2026).
Peanut Allergy Vaccine Market Taxonomy
On the basis of end user, the global peanut allergy vaccines market is classified into:
•Hospitals
•Medical Practitioners
•Government Agencies
•Personal Clinics
•Others
Government initiative towards creating awareness and regulatory approvals for peanut allergy vaccine
is necessary for the growth of the market. Some of the other treatment methods for peanut allergy are
oral immunotherapy and epinephrine treatment. However, neither of these treatments has gained
significant momentum in the peanut allergy treatment market.
Companies operating in the market in the current scenario are focusing on obtaining approval for their
products from the respective regulatory bodies. The major companies operating in the market are
Allergy Therapeutics, Zicam, Aravax, Immunomic Therapeutic, Inc., Astellas, and Aimmune.
Peanut Allergy Vaccine Market Outlook – Increasing prevalence of peanut allergy and lack of
proper treatment
Globally, incidence of peanut allergy is increasing supported by rising birth rate. The risk of peanut
allergy is more prevalent in countries such as the U.K., Australia, and the U.S. According to American
Academy of Allergy Asthma & Immunology, 30.4% of the children with food allergies suffered from
multiple allergy attacks. Peanut allergy is such an epidemic condition in the U.S. that the federal Food
Allergen Labeling and Consumer Protection Act (FALCPA) mandated that all packaged food sold in
the U.S. that include peanuts as an ingredient have to prominently display the word 'Peanut' on the
label. The only solution to peanut allergy is restraining a patient from having peanuts/peanuts
containing products. Nevertheless, peanut vaccine is capable of curing the ailment from a very young
age, without any restriction on food. Therefore, the future of the peanut allergy vaccine market is very
promising. Click To Read More On Peanut Allergy Vaccine Market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death.

Download Report